Detalhe da pesquisa
1.
Benzyl-para-di-[5-methyl-4-(n-octylamino) pyrimidin-2(1H)one] as an interferon beta (IFN-ß) modulator.
Mol Divers
; 26(4): 2175-2188, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668104
2.
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents.
ACS Med Chem Lett
; 14(9): 1275-1283, 2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736177
3.
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets.
Front Cell Infect Microbiol
; 11: 611304, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791235
4.
An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist.
Med Chem
; 14(7): 688-694, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29651942
5.
Structurally Simple, Readily Available Peptidomimetic 1-Benzyl-5-methyl-4-( n-octylamino)pyrimidin-2(1 H)-one Exhibited Efficient Cardioprotection in a Myocardial Ischemia (MI) Mouse Model.
J Med Chem
; 61(24): 11309-11326, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507195
6.
A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.
PLoS One
; 10(5): e0127549, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26024237